Treatment of end-stage renal failure after heart transplantation. 1998

L Frimat, and J P Villemot, and L Cormier, and T Cao-Huu, and E Renoult, and D Hestin, and C Dopff, and S Mattéi, and J Hubert, and M Kessler
Department of Nephrology, University Hospital, Nancy, France.

BACKGROUND Five to 10% of heart-transplant recipients develop end-stage renal failure (ESRF). Little is known about the outcome of these patients under renal replacement therapy. METHODS We conducted a retrospective study in 16 men (mean age 52.8+/-7.4 years at heart transplantation) who developed ESRF 5.3+/-2.1 years later. Results. Haemodialysis (HD) was the first-line treatment (mean Kt/V 1.35+/-0.4). Vascular access was unsuccessful in six patients (37.5%) due to peripheral arteriopathy and they were treated with tunnelled catheters for an average 15 months without bacterial infection. Mean weight was 68.4+/-10 kg at onset of HD and 61.7+/-9 kg one month later. Despite this reduction in extracellular overload, one antihypertensive drug was required in 75% of patients and two drugs in 12.5%. One patient tolerated automated peritoneal dialysis (PD) for 16 months (weekly Kt/V 2.1) despite persistent anuria. Renal transplantation (RT) was contraindicated in eight patients because of aortoiliac arteriopathy (n=5), poor general status (n=2), or ischaemic heart disease (n=1). RT was performed in eight patients with no acute episode of heart or renal graft rejection. There were no serious infectious complications. Three months after RT, mean serum creatinine was 115 micromol/l. One patient developed post-transplant lymphoproliferative disorder 3.5 months after RT and was successfully treated with transplant nephrectomy. Sudden death occurred in two patients 18 and 33 months after RT. Overall patient survival was 100, 78, and 59%, 1, 2 and 3 years after HD onset respectively. Using a time-dependent variable, the Cox model analysis demonstrated that heart-transplant recipients with ESRF have a relative risk of death 3.2 times higher than those without ESRF (95% CI = 1.3-7.8). CONCLUSIONS HD, PD, and RT can be useful for the treatment of ESRF after heart transplantation. After initiating HD, patient survival is nearly the same as that reported in patients in Europe undergoing HD for other causes. But ESRF seems to reduce life expectancy in heart-transplant recipients.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010530 Peritoneal Dialysis Dialysis fluid being introduced into and removed from the peritoneal cavity as either a continuous or an intermittent procedure. Dialyses, Peritoneal,Dialysis, Peritoneal,Peritoneal Dialyses
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D016027 Heart Transplantation The transference of a heart from one human or animal to another. Cardiac Transplantation,Grafting, Heart,Transplantation, Cardiac,Transplantation, Heart,Cardiac Transplantations,Graftings, Heart,Heart Grafting,Heart Graftings,Heart Transplantations,Transplantations, Cardiac,Transplantations, Heart

Related Publications

L Frimat, and J P Villemot, and L Cormier, and T Cao-Huu, and E Renoult, and D Hestin, and C Dopff, and S Mattéi, and J Hubert, and M Kessler
February 2004, Clinical transplantation,
L Frimat, and J P Villemot, and L Cormier, and T Cao-Huu, and E Renoult, and D Hestin, and C Dopff, and S Mattéi, and J Hubert, and M Kessler
July 1992, Journal of the American Veterinary Medical Association,
L Frimat, and J P Villemot, and L Cormier, and T Cao-Huu, and E Renoult, and D Hestin, and C Dopff, and S Mattéi, and J Hubert, and M Kessler
December 1993, Critical care nursing clinics of North America,
L Frimat, and J P Villemot, and L Cormier, and T Cao-Huu, and E Renoult, and D Hestin, and C Dopff, and S Mattéi, and J Hubert, and M Kessler
June 1971, Minnesota medicine,
L Frimat, and J P Villemot, and L Cormier, and T Cao-Huu, and E Renoult, and D Hestin, and C Dopff, and S Mattéi, and J Hubert, and M Kessler
September 1974, The Medical journal of Australia,
L Frimat, and J P Villemot, and L Cormier, and T Cao-Huu, and E Renoult, and D Hestin, and C Dopff, and S Mattéi, and J Hubert, and M Kessler
December 1998, Transplantation,
L Frimat, and J P Villemot, and L Cormier, and T Cao-Huu, and E Renoult, and D Hestin, and C Dopff, and S Mattéi, and J Hubert, and M Kessler
December 2003, Critical care nursing clinics of North America,
L Frimat, and J P Villemot, and L Cormier, and T Cao-Huu, and E Renoult, and D Hestin, and C Dopff, and S Mattéi, and J Hubert, and M Kessler
January 2000, Transplant international : official journal of the European Society for Organ Transplantation,
L Frimat, and J P Villemot, and L Cormier, and T Cao-Huu, and E Renoult, and D Hestin, and C Dopff, and S Mattéi, and J Hubert, and M Kessler
May 2001, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
L Frimat, and J P Villemot, and L Cormier, and T Cao-Huu, and E Renoult, and D Hestin, and C Dopff, and S Mattéi, and J Hubert, and M Kessler
June 2010, Kardiologia polska,
Copied contents to your clipboard!